distribution of drug dr. muslim suardi faculty of pharmacy university of andalas 2009
TRANSCRIPT
DISTRIBUTIONDISTRIBUTION OF DRUGOF DRUGDr. Muslim SuardiDr. Muslim Suardi
Faculty of Pharmacy Faculty of Pharmacy University of Andalas University of Andalas
20092009
DistributionDistribution of Drug of Drug
After absorption
or
Injected intravenously
Heart
Bloodstream
IntroductionIntroduction
Once a drug has gained excess to the blood stream, it is subjected to a number of processes called as Disposition Processes that tend to lower the Cp.
1.Distribution: Reversible transfer of a drug between compartments.
2.Elimination: Irreversible loss of drug from the body. It comprises of biotrans- formation & excretion.
DistributionDistribution of Drug of Drug
Involves reversible transfer of a drug between compartments.
Drug molecules are distributed is throughout the body by systemic circulation
Drug Distribution Drug Distribution
“Reversible transfer of drug from one site to another within the body”
Drug Distribution Drug Distribution
Reversible Transfer of a Drug between:
Blood
Extra Vascular Fluids
Tissues of the body
(Fat, muscle, & brain tissue)
Distribution ProcessDistribution Process
• Distribution is a Passive Process
• Driving force is the concentration gradient between the blood &
extravascular tissues
Drug in Drug in Systemic CirculationSystemic Circulation
Unbound
Bound
Diffusion of Diffusion of DDrugrug
Diffusion of unbound drug until equilibrium is established.
Distribution of DrugDistribution of Drug
By blood to:
1. Receptor
2. Non receptor, caused side effects
3. Eliminating organs: liver & kidneys
4. Tissues: brain, skin & muscle
5. Placenta, breast milk
6. Bound to proteins in the plasma & tissues
7. Fat
Distribution in TissueDistribution in Tissue
Distribution of a drug is not uniform throughout the body because different
tissues receive the drug from plasma at different rates & to different extents.
Factors Factors AAffecting ffecting DDrug rug DDistributionistribution
Rate of distribution• Membrane permeability • Blood perfusion
Extent of Distribution• Lipid Solubility • pH - pKa • Plasma protein binding • Intracellular binding
Circulatory SystemCirculatory System
• Artery: which carry blood to tissues
• Veins: which return blood back to the heart
• BW 70 kg, 5L of blood, 3 L plasma
• 50% of the blood is in large veins or venous sinuses
• Mixing of drug in the blood occurs rapidly
Circulatory SystemCirculatory System
• Drug molecules rapidly diffuse through fine capillaries to the tissues filled with interstitial fluid
• Interstitial fluid + plasma water is termed the extracellular water
Drug Drug MMolecules olecules AAcross cross CCell ell MMembraneembrane
Depend upon:
• Physicochemical nature of both the drug & the cell membrane
• Cell membrane: Protein & bi-layer of phospholipid
• Lipid-soluble drug more easily
• Drug-protein complex: too large
Drugs Transverse ProcessDrugs Transverse Process
Passive diffusion (mainly)
Hydrostatic pressure
Passive Passive DDiffusioniffusion
Drug molecules move from high to low
Fick’s Law of Diffusion
Distribution is a Passive Process
Driving force is the conc. gradient between the blood & extravascular tissues
DiffusionDiffusion
Diffusion of unbound drug until equilibrium is established.
Fick’s Law of Diffusion Fick’s Law of Diffusion
Rate of drug diffusion
dQ/dt = -DKA/h (Cp-Ct)
• D = the diffusion constant
• K = the lipid-water partition coefficient
• A = the surface area of the membrane
• h = the thickness of the membrane
Hydrostatic pressureHydrostatic pressure
Figure !
Role of DistributionRole of DistributionPharmacological action of a drug depends upon its concentration at the site of action
So that,
Distribution plays a significant role in the:
Onset,
Intensity, &
Duration of action.
UniformUniformity of Dity of Drugrug DistributionDistribution
Distribution of a drug is not Uniform throughout the body because different
tissues receive the drug from plasma at different rates & to different extents.
PPatternsatterns of Drug D of Drug Distributionistribution
1.The drug may remain largely within the vascular system.
Ex: Plasma substitutes such as dextran & drugs which are strongly bound to plasma protein
PPatternsatterns of Drug D of Drug Distributionistribution
2.Some are uniformly distributed throughout the body water.
Ex: low MW water soluble compounds (EtOH) & a few sulfonamides
PPatternsatterns of Drug D of Drug Distributionistribution
3.A few drugs are concentrated specifically in one or more tissues that may or may not be the site of action.
Ex: Iodine (in the thyroid gland), chloroquine (in the liver even at conc 1000 times those present in plasma), tetracycline (irreversibly bound to bone & developing teeth) & highly lipid soluble compounds (distribute into fat tissue)
PPatternsatterns of Drug D of Drug Distributionistribution
4.Most drugs exhibit a non-uniform distribution in the body (largely determined by the ability to pass through membranes & their lipid/water solubility). The highest concentrations are often present in the kidneys, liver, & intestine.
VVolume of Distributionolume of Distribution
Apparent Vd: to quantify the distribution of a drug between plasma & the rest of the body after oral or parenteral dosing.
Called as Apparent Volume because all parts of the body equilibrated with the drug do not have equal conc.
The drug would be uniformly distributed to produce the observed blood conc.
Factors Related with the Factors Related with the Differences Differences ofof Drug Distribution Drug Distribution
1. Tissue Permeability of the Druga. Physiochemical Properties of the drug
eg. MW, pKa & o/w Partition coefficient.
b. Physiological Barriers to Diffusion of
Drugs.
2. Organ/Tissue Size & Perfusion Rate
Factors Related with the Factors Related with the Differences Differences ofof Drug Distribution Drug Distribution
3. Binding of Drugs to Tissue Component
(Blood components & Extravascular
Tissue Proteins)
4. Miscellaneous Factors Age, Pregnancy, Obesity, Diet, Disease
states, & DI.
Tissue Permeability of the Tissue Permeability of the DrugsDrugs
Depends Upon: 1. Rate of Tissue Permeability
2. Rate of Blood Perfusion.
The Rate of The Rate of TTissue issue PPermeabilityermeability
Depends upon:
1. Physicochemical nature of the drug
2. Physiological barriers that restrict the
diffusion of drug into tissues.
Physiochemical Properties that Physiochemical Properties that IInfluence nfluence DDrug rug DDistributionistribution
MW
pKa
o/w Partition coefficient.
Diffusion of Drug MoleculeDiffusion of Drug Molecule
• Drugs having MW <400D easily cross the capillary membrane to diffuse into the extracellular interstitial fluids.
• Penetration of drug from the Extracellular Fluid (ECF) is a function of MW & ionization
Diffusion Related with MW & Diffusion Related with MW & IonizationIonization
* Molecular Size:
Small ions of size <50D enter the cell through aqueous filled channels where as larger size ions are restricted unless a specialized transport system exists for them.
* Ionisation
A drug that remains unionized at pH values of blood & ECF can permeate the cells more rapidly.
Blood & ECF pH normally remains constant at 7.4, unless altered in conditions like systemic alkalosis/acidosis
LipophilicityLipophilicity
Only unionized drugs that are lipophilic rapidly crosses the cell membrane
e.g. Thiopental, a lipophilic drug, largely unionized at blood & ECF pH readily diffuses the brain where as Penicillins which are polar & ionized at plasma pH do not cross BBB.
PENETRATION OF DRUGS PENETRATION OF DRUGS THROUGH BTHROUGH BBBBB
• A stealth of endothelial cells lining the capillaries.• It has tight junctions & lack large intra cellular pores.• Further, neural tissue covers the capillaries.• Together, they constitute the BBB• Astrocytes: Special cells/elements of supporting tissue
are found at the base of endothelial membrane.• The BBB is a separation of circulating blood & CSF
maintained by the choroid plexus in the CNS.
BBBBBB
• BBB is a lipoidal barrier
• It allows only the drugs having high o/w partition coefficient to diffuse passively where as moderately lipid soluble & partially ionized molecules penetrate at a slow rate.
BBBBBB
• Endothelial cells restrict the diffusion of microscopic objects (e.g. bacteria ) & large or hydrophillic molecules into the CSF, while allowing the diffusion of small hydrophobic molecules (O2, CO2,
hormones).Cells of the barrier actively transport metabolic products such as glucose across the barrier with specific proteins.
Various Various AApproaches to pproaches to PPromote romote CCrossing BBBrossing BBB
• Use of permeation enhancers: DMSO.
• Osmotic disruption of the BBB by infusing internal carotid artery with mannitol.
• Use of Dihydropyridine Redox system as drug carriers to the brain (the lipid soluble dihydropyridine is linked as a carrier to the polar drug to form a prodrug that rapidly crosses the BBB )
PENETRATION OF DRUGS THROUGHPENETRATION OF DRUGS THROUGH PLACENTAL BARRIER PLACENTAL BARRIER
• Placenta is the membrane separating fetal blood from the maternal blood.
• It is made up of fetal trophoblast basement membrane the endothelium.
• Mean thickness in early pregnancy is (25 µm) which reduces to (2µm) at full term.
RedistributionRedistribution
Highly lipid soluble drugs when given by i.v. or by inhalation initially get distributed to organs with high blood flow, e.g. brain, heart, kidney etc.
Later, less vascular but more bulky tissues (muscles, fat) take up the drug & Cp falls & drug is withdrawn from these sites.
RedistributionRedistribution
If the site of action of the drug was in one of the highly perfused organs, redistribution results in termination of the drug action
Greater the lipid solubility of the drug, faster is its redistribution.
RedistributionRedistribution
If the site of action of the drug was in one of the highly perfused organs, redistribution results in termination of the drug action.
Greater the lipid solubility of the drug, faster is its redistribution.
Drug Distribution & tDrug Distribution & t1/2el1/2el
• Drug elimination is mainly governed by renal & other metabolic processes
• Extensive drug distribution has the effect of diluting in a large volume, harder for the kidney to filter by GF
• t1/2 el is prolonged if Cl is constant & Vd is increased
• t1/2 el = 0.693 Vd/Cl
Clinical ExamplesClinical Examples
Large Vd & long t1/2el
• Dirithromycin is extensively distributed in the tissues resulting in a large SS Vd of ± 800L. t1/2el in human ± 44h, large total body Cl 226-1040 mL/min, & given s.i.d. Small Cl generally leads to a longer t1/2el. In this case, Cl is large but t1/2el is longer because of the large Vd.
Clinical ExamplesClinical Examples
Small Vd & a long t1/2el
• Tenoxicam, is a NSAID • 99% bound to plasma protein, t1/2el of 67h• Low lipophilicity & highly ionized• Very polar, drug penetrates membranes slowly• Synofial fluid peak level only 1/3 plasma, occurs
20h later than plasma• Drug poorly distributed to body tissues, Vd 9.6L• In this case: t1/2el is long because the plasma
tenoxicam cl is so small that dominates
Drug AccumulationDrug Accumulation
Depend upon:
Blood flow
Affinity of the drug for the tissue
Processes of Drug AccumulationProcesses of Drug Accumulation
• Affinity of the drug for the tissue
• Concentrated drug in the adipose tissue
• Binding of drug to proteins or other macromolecules in tissue
• Drug is irreversible bound into a particular tissue
Affinity of Affinity of TThe he DDrug for rug for TThe he TTissue issue
• Uptake of the drug into the tissue is generally controlled by the difussional barrier of the capillary membrane & other cell membrane
• Brain is well perfused with blood, but many drugs with good aqueous solubility have high kidney, liver, & lung concentration, & yet little brain drug concentration.
Concentrated Concentrated DDrug in rug in TThe he AAdipose dipose TTissueissue
• Drug uptake into a tissue is generally reversible
• Drugs with a high lipid/water partition coefficient are very fat soluble & tend to accumulate in adipose tissue.
• Because of the extraction of drug out of the tissue is so slow.
• Drug may remain for days
Concentrated Concentrated DDrug in rug in TThe he AAdipose dipose TTissue issue
• Adipose tissue is poorly perfused with blood, accumulation is slow
• Once the drug is concentrated in fat tissue, removal from fat may also be slow
• DDT is highly lipid soluble & remains in fat tissue for years!
Binding of Binding of DDrug to rug to PProteins or roteins or OOther ther MMacromoleculesacromolecules
• Digoxin is highly bound to proteins in cardiac tissues, large Vd 440L & long t1/2el 40h
• Some drugs may complex with melanin in the skin & eye (long term phenotiazine)
• Tetra forms an insoluble chelate with Ca
• Amphetamine is actively transported into adrenergic tissue
Drug is Drug is IIrreversible rreversible BBound ound IInto a nto a PParticular articular TTissueissue
• Drug/reactive intermediate metabolite become covalently bound to a macromolecule within the cell
• Many purine & pyrimidine used in cancer therapy are incorporated into nucleic acids, causing destruction of the cell
DDistribution & Pharmacodynamicistribution & Pharmacodynamic
• Onset of drug action depends upon the rate of unbound drug that reaches the receptor at a MEC to produce a PD response
• Onset time is often dependent upon the rate of drug uptake & distribution to the receptor site
• The intensity of a drug action depends upon the total drug concentration of the receptor site & the number of receptor occupied by drug
Effect of Binding on Effect of Binding on VVdd
• Extend of protein binding in plasma or tissue will affect Vd
• Drugs highly bound to plasma proteins will have a low fraction of free drug in plasma water, harder to diffuse, & less extensively distributed to tissues
• Drugs with low plasma protein binding have greater unbound fraction, easier diffusion & greater Vd
Protein Binding Protein Binding
Protein BindingProtein Binding
Many drugs interact with:
• Plasma Proteins
• Tissue Proteins
• Macromolecules: melanin, DNA
To form a macromolecule complex
Drug-Protein BindingDrug-Protein Binding
Process:
Reversible
Irreversible
ReversibleReversible
Weaker chemical bonds:
Hydrogen bond
van der Waals forces
IrreversibleIrreversible
Strongly by covalent chemical bonding
• Toxicity for a long time period (chemical carcinogenic) or
• Short time period (reactive chemical intermediates)
• Ex: PCT, reactive metabolite intermediate interact with liver proteins
Plasma Proteins Plasma Proteins
Albumin
Acid glycoprotein
Lipoproteins
Studying Protein BindingStudying Protein Binding
• Equilibrium dialysis • Dynamic dialysis • Diafiltration • Ultrafiltration• Gel chromatography • Spectrophotometry • Electrophoresis • Optical rotary dispersion & circulatory dichroism
Important Factors in Binding Important Factors in Binding
1. The drug
2. The protein
3. The affinity between drug & protein
4. Drug interaction
5. The pathophysiologic condition of the
patient
1. The drug1. The drug
• Physicochemical properties of the drug
• Total concentration of the drug in the body
2. The protein2. The protein
1. Quantity of protein available for drug-protein binding
2. Quality of physicochemical nature of the protein synthesized
3. Affinity 3. Affinity BBetween etween DDrug & rug & PProteinrotein
Includes the magnitude of the association constant
4. Drug 4. Drug IInteractionnteraction
• Competition for the drug by other substances at a protein-binding site
• Alteration of the protein by a substance that modifies the affinity of the drug for the protein.
• Ex: aspirin acetylates lysine residues of albumin
5. Pathophysiologic Condition5. Pathophysiologic Condition
Example:
Drug-protein binding may be reduced in uremic patients & in patients with hepatic
disease
REFERENCESREFERENCES
• Shargel, Wu-Pong & Yu, 2004.
• Rani & Hiremath, 2000.
• Brahmankar & Jaiswal, 2008.
• Gibaldi, 1982.